Qi-En Wang

16PUBLICATIONS
67CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical devicesCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 28, 2026
Inhibition of Translesion DNA Synthesis Sensitizes BRCA-Deficient Ovarian Cancer to PARP Inhibitors.

|Sep 15, 2026
Racial Disparities in Survival Outcomes for Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A SEER-Based Retrospective Analysis (2010-2020).

|Sep 04, 2026
STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation.

|Feb 27, 2026
Intracellular Delivery of Peptides and Proteins with an Engineered Membrane Translocation Domain.

Prabhat Bhat, Heba Salim, Jeremy L Ritchey

|Jan 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition.

Yaogang Zhong, Feng Geng, Huali Su

|Oct 13, 2025
BNIP3L/BNIP3-Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells.

Na Li, Tejinder Pal Khaket, Yajing Yang

Pageof 3

Frequent Collaborators

8 joint publications

Junran Zhang

6 joint publications

Zaibo Li

4 joint publications

Chandra Bhushan Prasad

3 joint publications

Deliang Guo